Stephen Rennard
Overview
Explore the profile of Stephen Rennard including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
99
Citations
4989
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Erion D, Liu L, Brown C, Rennard S, Farah H
Chest
. 2024 Oct;
167(2):444-452.
PMID: 39401571
Topic Importance: Alpha-1 antitrypsin (AAT) deficiency is a genetic disorder most commonly due to a single G to A point mutation (E342K), leading to debilitating lung and/or liver disorders and...
2.
Girardi M, Roman M, Porszasz J, Stringer W, Rennard S, Ferguson C, et al.
J Appl Physiol (1985)
. 2024 Aug;
137(5):1130-1144.
PMID: 39205640
Quantitating exercise ventilatory and gas exchange dynamics affords insights into physiological control processes and cardiopulmonary dysfunction. We designed a novel waveform, the chirp waveform, to efficiently extract moderate-intensity exercise response...
3.
Gerard S, Dougherty T, Nagpal P, Jin D, Han M, Newell Jr J, et al.
Ann Am Thorac Soc
. 2024 Mar;
21(7):1022-1033.
PMID: 38530051
Rates of emphysema progression vary in chronic obstructive pulmonary disease (COPD), and the relationships with vascular and airway pathophysiology remain unclear. We sought to determine if indices of peripheral (segmental...
4.
Casaburi R, Merrill D, Leidy N, Locantore N, Dolmage T, Garcia-Aymerich J, et al.
Ann Am Thorac Soc
. 2023 Dec;
21(5):727-739.
PMID: 38109693
A COPD Foundation working group sought to identify measures of exercise endurance, a meaningful aspect of physical functioning in everyday life among patients with chronic obstructive pulmonary disease (COPD) that...
5.
Dai H, Nollen N, Rennard S, Guenzel N, Pham H, Khan A
Drug Alcohol Depend
. 2023 Oct;
252:110984.
PMID: 37804563
Objective: Provide evidence on racial and ethnic differences in biomarkers of exposure from rising e-cigarette use among U.S. adults. Methods: Data were drawn from Waves 1-5 of the Population Assessment...
6.
McKleroy W, Shing T, Anderson W, Arjomandi M, Awan H, Barjaktarevic I, et al.
JAMA
. 2023 Aug;
330(5):442-453.
PMID: 37526720
Importance: People who smoked cigarettes may experience respiratory symptoms without spirometric airflow obstruction. These individuals are typically excluded from chronic obstructive pulmonary disease (COPD) trials and lack evidence-based therapies. Objective:...
7.
Rabe K, Rennard S, Martinez F, Celli B, Singh D, Papi A, et al.
Am J Respir Crit Care Med
. 2023 Jun;
208(4):395-405.
PMID: 37348121
Chronic obstructive pulmonary disease (COPD) is a complex, heterogeneous, progressive inflammatory airway disease associated with a significant impact on patients' lives, including morbidity and mortality, and significant healthcare costs. Current...
8.
Casaburi R, Merrill D, Dolmage T, Garcia-Aymerich J, Fageras M, Goldstein R, et al.
Chronic Obstr Pulm Dis
. 2022 Sep;
9(4):520-537.
PMID: 36066494
Introduction: The COPD Biomarkers Qualification Consortium (CBQC) was formed under COPD Foundation management, with the goal of qualifying biomarkers and clinical outcome assessments through established regulatory processes for chronic obstructive...
9.
Usmani O, Han M, Kaminsky D, Hogg J, Hjoberg J, Patel N, et al.
Chest
. 2022 Apr;
161(4):e249-e250.
PMID: 35396060
No abstract available.
10.
Baugh A, Shiboski S, Hansel N, Ortega V, Barjaktarevic I, Barr R, et al.
Am J Respir Crit Care Med
. 2021 Dec;
205(7):819-829.
PMID: 34913855
African American individuals have worse outcomes in chronic obstructive pulmonary disease (COPD). To assess whether race-specific approaches for estimating lung function contribute to racial inequities by failing to recognize pathological...